These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12742559)

  • 21. Comparison of two triphasic oral contraceptives containing either gestodene or norethindrone: a randomized, controlled trial.
    Weber-Diehl F; Lehnert J; Lachnit U
    Contraception; 1993 Oct; 48(4):291-301. PubMed ID: 8222658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 microg ethinylestradiol/100 microg levonorgestrel and 20 microg ethinylestradiol/500 microg norethisterone.
    Endrikat J; Hite R; Bannemerschult R; Gerlinger C; Schmidt W
    Contraception; 2001 Jul; 64(1):3-10. PubMed ID: 11535206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 microg and ethinylestradiol 15 microg.
    Eur J Contracept Reprod Health Care; 1999 Nov; 4 Suppl 2():9-15. PubMed ID: 14677620
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical experience in Switzerland with the new monophasic oral contraceptive Minulet (75 mcg gestodene, 30 mcg ethinyl oestradiol).
    Privrel T; Daubenfeld O
    Br J Clin Pract; 1988 Jul; 42(7):292-8. PubMed ID: 3075505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 microg and ethinylestradiol 15 microg (Minesse).
    Barbosa IC; Filho CI; Faggion D; Baracat EC
    Contraception; 2006 Jan; 73(1):30-3. PubMed ID: 16371291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical experiences with femovan (Gynera)].
    Brill K; Düsterberg B; Albring M
    Ther Umsch; 1990 Dec; 47(12):958-65. PubMed ID: 2096480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A clinical overview of a new triphasic contraceptive containing gestodene.
    Christie T
    Int J Fertil; 1989 Sep; 34 Suppl():40-9. PubMed ID: 2576257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 microg ethinyl estradiol and 75 microg gestodene and a 21-day regimen with 30 microg ethinyl estradiol and 75 microg gestodene on hemostatic variables, lipids, and carbohydrate metabolism.
    Endrikat J; Klipping C; Gerlinger C; Ruebig A; Schmidt W; Holler T; Düsterberg B
    Contraception; 2001 Oct; 64(4):235-41. PubMed ID: 11747873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
    Merz M; Kroll R; Lynen R; Bangerter K
    Contraception; 2015 Feb; 91(2):113-20. PubMed ID: 25453585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women.
    Paoletti AM; Orrù M; Floris S; Mannias M; Vacca AM; Ajossa S; Guerriero S; Melis GB
    Contraception; 2000 Apr; 61(4):259-63. PubMed ID: 10899481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of two low-dose gestodene containing monophasic oral contraceptives on hemostasis in Bulgarian women.
    Uchikova E; Pehlivanov B
    Expert Opin Pharmacother; 2008 Aug; 9(11):1839-44. PubMed ID: 18627323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect on blood pressure of a monophasic oral contraceptive containing ethinylestradiol and gestodene.
    Fuchs N; Düsterberg B; Weber-Diehl F; Mühe B
    Contraception; 1995 Jun; 51(6):335-9. PubMed ID: 7554972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen.
    Parsey KS; Pong A
    Contraception; 2000 Feb; 61(2):105-11. PubMed ID: 10802275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of a combined oral contraceptive: gestodene 75 micrograms plus ethinyl estradiol 30 micrograms in Mexican women.
    Garza-Flores J; Valles de Bourges V; Martínez M; Vázquez-Estrada L; Bassol S; Recio R; Pérez-Palacios G
    Adv Contracept; 1994 Mar; 10(1):19-26. PubMed ID: 8030449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Minimizing the problem of poor compliance in adolescents. Clinical experience with a modern low-dose gestodene-containing oral contraceptive.
    Brill K
    Ann N Y Acad Sci; 1997 Jun; 816():457-65. PubMed ID: 9238302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen.
    Brucker C; Hedon B; The HS; Höschen K; Binder N; Christoph A
    Contraception; 2010 Jun; 81(6):501-9. PubMed ID: 20472117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, cycle control and side-effects of two monophasic combination oral contraceptives: gestodene/ethinylestradiol and norgestimate/ethinylestradiol.
    Affinito P; Monterubbianesi M; Primizia M; Regine V; Di Carlo C; Farace MJ; Petrillo G; Nappi C
    Gynecol Endocrinol; 1993 Dec; 7(4):259-66. PubMed ID: 8147235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The acceptance of a 7-week cycle with a modern low-dose oral contraceptive (Minulet).
    Kornaat H; Geerdink MH; Klitsie JW
    Contraception; 1992 Feb; 45(2):119-27. PubMed ID: 1559335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.